Survival benefit from S-1 as compared to Fluorouracil in Asian patients with advanced gastrointestinal cancer: A meta-analysis

Whether S-1 could replace 5-Fluorouracil (5-Fu) or not in the treatment of advanced gastrointestinal (GI) cancer (including advanced gastric cancer [AGS] and metastatic colorectal cancer [mCRC]) in Asian patients has been controversial. This meta-analysis was performed to compare the activity, effic...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Chunxiang, Zhang, Xunlei, Kuang, Meng, Gu, Dongying, He, Mingliang, Chen, Jinfei, Tang, Cuiju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317849/
https://www.ncbi.nlm.nih.gov/pubmed/24974863
http://dx.doi.org/10.1111/cas.12465

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317849/
https://www.ncbi.nlm.nih.gov/pubmed/24974863
http://dx.doi.org/10.1111/cas.12465

Ejemplares similares